Gaps in care for rheumatoid arthritis: A population study

Arthritis Care and Research

Volumn 53, Issue 2, 2005, Pages 241-248

  Lacaille, Diane ^a,c   Anis, Aslam H ^a   Guh, Daphne P ^b   Esdaile, John M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Ctr Hlth Eval and Outcome Sci   (Canada)

^c ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

Author keywords

Health care; Health services; Patterns of care; Population study; Quality of care; Rheumatoid arthritis; Treatment guidelines

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GOLD; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ARTHRODESIS; ARTHROPATHY; ARTHROPLASTY; ARTICLE; CANADA; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PHYSIOTHERAPY; PLASTIC SURGERY; PRACTICE GUIDELINE; PREVALENCE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SYNOVECTOMY; TENDON RECONSTRUCTION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BRITISH COLUMBIA; COHORT STUDIES; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE;

EID: 17244382894     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21077     Document Type: Article

References (28)

1. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
2. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996;39:713-22.
3. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002; 46:328-46.
4. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290-7.
5. British Society for Rheumatology, and the Research Unit of the Royal College of Physicians. Guidelines and audit measures for the specialist supervision of patients with rheumatoid arthritis. J R Coll Physicians Lond 1992;26:76-82.
6. Sokka T, Mottonen T, Hannonen P. Disease-modifying antirheumatic drug use according to the "sawtooth" treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature. Rheumatology (Oxford) 2000;39:34-42.
7. Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum 1996;39:616-22.
8. Abu-Shakra M, Toker R, Flusser D, Flusser G, Friger M, Sukenik S, et al. Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs. Arthritis Rheum 1998;41:1190-5.
9. Munro R, Hampson R, McEntegart A, Thomson EA, Madhok R, Capell H. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann Rheum Dis 1998;57:88-93.
10. Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, M'Seffar A, et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 2000;27:623-9.
11. Van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 1996;124:699-707.
12. Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51.
13. Buckland-Wright JC, Clarke GS, Chikanza IC, Grahame R. Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. J Rheumatol 1993;20:243-7.
14. Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995;22:2208-13.
15. Pincus T, O'Dell JR, Kremer JM. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy. Ann Intern Med 1999;131:768-74.
16. Fries JF. Current treatment paradigms in rheumatoid arthritis. Rheumatology (Oxford) 2000;39 Suppl 1:30-5.
17. Wollheim FA. Approaches to rheumatoid arthritis in 2000. Curr Opin Rheumatol 2001;13:193-201.
18. MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284:984-92.
19. Ward MM, Leigh JP, Fries JF. Progression of functional disability in patients with rheumatoid arthritis: associations with rheumatology subspecialty care. Arch Intern Med 1993;153:2229-37.
20. Yelin EH, Such CL, Criswell LA, Epstein WV. Outcomes for persons with rheumatoid arthritis with a rheumatologist versus a non-rheumatologist as the main physician for this condition. Med Care 1998;36:513-22.
21. Criswell LA, Such CL, Yelin EH. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. J Rheumatol 1997;24:2283-90.
22. Gabriel SE, Wagner JL, Zinsmeister AR, Scott CG, Luthra HS. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists? Arthritis Rheum 2001;44:1504-14.
23. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46:1075-9.
24. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases. J Clin Epidemiol 1996;49:1429-33.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
26. Silman A, Hochberg MC. Rheumatoid arthritis. In: Silman A, Hochberg MC, editors. Epidemiology of the rheumatic diseases. Oxford: Oxford Press; 1993. p. 7-68.
27. Shipton D, Guan J, Badley E. Where you live affects your chance of having received DMARD therapy [abstract]. Arthritis Rheum 2002;46:S87.
28. MacLean CH, Park GS, Traina SB, Liu HH, Hahn BH, Paulus HE, et al. Positive predictive value (PPV) of an administrative data-based algorithm for the identification of patients with rheumatoid arthritis (RA) [abstract]. Arthritis Rheum 2001;44:S106.